Related Experiment Video
Updated: Feb 25, 2026
07:33
Tethered Bilayer Lipid Membranes to Monitor Heat Transfer between Gold Nanoparticles and Lipid Membranes
Published on: December 8, 2020
3.1K
Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobe
J Gallo1, B I Harriss, J Hernández-Gil
1Advanced (magnetic) Theranostic Nanostructures Group, International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga s/n 4715-330, Braga, Portugal.
Nanoscale
|August 2, 2017
Summary
This study introduces a novel dual T1-T2 magnetic resonance imaging (MRI) contrast agent. The agent utilizes temperature-responsive nanoparticles to improve diagnostic accuracy and reduce artifacts in MRI scans.
Area of Science:
- Biomedical Engineering
- Materials Science
- Radiology
Background:
- Magnetic Resonance Imaging (MRI) diagnostics are complex and specialized.
- Dual T1-T2 contrast agents offer potential simplification by reducing artifacts and providing double-checked results.
- Existing dual MRI probes have yielded inconsistent outcomes.
Purpose of the Study:
- To develop and characterize a novel dual T1-T2 MRI contrast agent.
- To investigate the temperature-dependent modulation of paramagnetic and superparamagnetic species.
- To overcome limitations of traditional nanotechnology, such as batch-to-batch variability.
Main Methods:
- Preparation of a dual T1-T2 MRI probe using superparamagnetic nanoparticles, Gd3+ chelates, and pNIPAM.
- Relaxometric studies to evaluate the probe's performance.
- Temperature variation to modulate the distance between paramagnetic and superparamagnetic components.
Main Results:
- Successful preparation and characterization of the dual T1-T2 MRI probe.
- Demonstration of temperature-dependent modulation of magnetic properties.
- Establishment of within-probe comparisons to mitigate batch variability.
Conclusions:
- The developed probe offers a promising approach to simplify MRI diagnostics.
- Temperature-responsive modulation provides a novel mechanism for controlling contrast properties.
- This strategy addresses key limitations in the development of dual MRI contrast agents.
